1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Autistic Disorder in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin Lorenzo, S | 1 |
| Nalesso, V | 1 |
| Chevalier, C | 1 |
| Birling, MC | 1 |
| Herault, Y | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Autistic Disorder
| Article | Year |
|---|---|
Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alleles; Animals; Autism Spectrum Disorder; Autistic | 2021 |